New drug approval process : accelerating global registrations / edited by- Guarino, Richard A.
Contributor(s): Guarino, Richard A
Material type: 
TextLanguage: English Series: Drugs and the pharmaceutical sciencesPublisher: New York : Marcel Dekker, Inc., c2004Edition: 4th edDescription: xiv, 635 p. : figures, tables, ill. ; 22 cmISBN: 0824750411 Hard bound; 9780824750411Subject(s): Drug Approval | Drug Evaluation | Clinical Trials as TopicDDC classification: 615.10973 Online resources: WorldCat details | Ebook Fulltext | Item type | Current location | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|---|---|
E-Book
|
EWU Library E-book | Non-fiction | 615.10973 NEW 2004 (Browse shelf) | Not for loan | ||||
Text
|
EWU Library Reserve Section | Non-fiction | 615.10973 NEW 2004 (Browse shelf) | C-1 | Not For Loan | 19384 | ||
|
Text
|
EWU Library Circulation Section | Non-fiction | 615.10973 NEW 2004 (Browse shelf) | C-2 | Available | 19385 | ||
|
Text
|
EWU Library Circulation Section | Non-fiction | 615.10973 NEW 2004 (Browse shelf) | C-3 | Available | 19386 |
Browsing EWU Library shelves, Shelving location: Circulation Section Close shelf browser
|
|
|
|
|
|
|
||
| 615.1078 SIP 1997 Pharmacology laboratory manual : | 615.1078 SIP 1997 Pharmacology laboratory manual : | 615.10973 NEW 2004 New drug approval process : | 615.10973 NEW 2004 New drug approval process : | 615.13 COO 1975 Cooper and Gunn's dispensing for pharmaceutical students / | 615.13 COO 1975 Cooper and Gunn's dispensing for pharmaceutical students / | 615.13 COO 1975 Cooper and Gunn's dispensing for pharmaceutical students / |
Includes Bibliographical References and Index.
Part I : Regulatory practices and procedures of new drug, biologic and device development --
Drug development teams --
Nonclinical drug development --
The investigational new drug application and the investigator's brochure --
General considerations of the new drug application --
The new drug application, content and format --
Abbreviated and supplemental new drug applications --
The biologics license application --
Device legislation and application --
Orphan drugs --
Part II : Clinical research development --
Adverse experiences, adverse reactions, interactions of drugs --
Biostatistics in pharmaceutical product development --
Industry and FDA liasion --
Part III : Specific aspects in the process of new product submissions --
Chemistry, manufacturing, and control requirements of the NDA and ANDA --
Data presentation for FDA submissions --
Preparing for FDA inspections --
Technology change --
The common technical document for the registration of pharmaceutical for human use --
Part IV : Global applications of good clinical practices --
Obligations of the investigator, sponsor, monitor --
Instituitional review board --
Quality assurance --
Managing clinical trials --
The European union directive on good clinical parctice in clinical trials --
HIPAA --
Part V : Effective and new methodologies in expediting new product approvals in the US and European union --
Working with a CRO --
The evolving SMO in the US --
Accelerating new product approvals. Table of contents
Clarifying how to develop and market new drugs efficiently and economically for global markets, this text covers the emphasis on over-the-counter drugs in the long-range plans of many companies and discusses licence applications review boards.
Pharmacy
There are no comments for this item.